Market revenue in 2023 | USD 3,628.4 million |
Market revenue in 2030 | USD 10,686.1 million |
Growth rate | 16.7% (CAGR from 2023 to 2030) |
Largest segment | Filtration |
Fastest growing segment | Cell Culture & Mixing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Filtration, Cell Culture & Mixing, Storage, Sampling, Fill-finish Applications, Other Applications |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Sartorius AG, Danaher Corp, Avantor Inc, Lonza Group Ltd, Compagnie de Saint-Gobain SA, Corning Inc, Entegris Inc, Kuhner Shaker |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single use assemblies market will help companies and investors design strategic landscapes.
Filtration was the largest segment with a revenue share of 28.8% in 2023. Horizon Databook has segmented the U.S. single use assemblies market based on filtration, cell culture & mixing, storage, sampling, fill-finish applications, other applications covering the revenue growth of each sub-segment from 2018 to 2030.
The substantial share of the U.S. in the regional market can be attributed mainly to the presence of large-scale manufacturing facilities for biopharmaceuticals. The biopharmaceutical sector is considered the most R&D-intensive in the U.S., and its development is recognized as a high-impact factor in the industry.
Consequently, this can drive the adoption of single-use assemblies in the coming years for a flexible and fast approach, thus leading to significant revenue generation in the U.S. Furthermore, the U.S. FDA has estimated that it will be approving around 10 to 20 cell & gene therapy products each year by 2025 due to the current clinical success rates and promising product pipeline.
This can result in the rapid adoption of disposable containers and other single-use equipment in the biopharmaceutical industry, which can help curb the demand-supply gap in the coming years. Moreover, many companies are involved in developing their manufacturing capabilities to support the increasing demand.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. single use assemblies market , including forecasts for subscribers. This country databook contains high-level insights into U.S. single use assemblies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account